Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials. | 2023 | The Lancet |
Acute kidney injury in COVID-19 patients receiving remdesivir: a systematic review and meta-analysis of randomized clinical trials. | 2023 | Clinics |
Remdesivir for the treatment of COVID-19. | 2023 | The Cochrane Database of Systematic Reviews |
A systematic review and meta-analysis of randomized controlled trials with trial sequence analysis of remdesivir for COVID-19 treatment. | 2023 | International Journal of Critical Illness and Injury Science |
Remdesivir-induced bradycardia and mortality in sars-cov-2 infection, potential risk factors assessment: a systematic review and meta-analysis. | 2023 | Journal of Clinical Medicine |
The effects of remdesivir on mortality and the requirement for mechanical ventilation in patients with COVID-19: a systematic review stratified by disease severity. | 2023 | The Korean Journal of Internal Medicine |
Comparative efficacy and safety of anti-infective drugs for patients with mild to severe COVID-19: a systematic review and network meta-analysis of randomized controlled trials. | 2023 | Ethiopian Medical Journal |
Remdesivir for pregnancy: a systematic review of antiviral therapy for COVID-19. | 2022 | Heliyon |
Potentially effective drugs for the treatment of COVID‑19 or MIS‑C in children: a systematic review. | 2022 | European Journal of Pediatrics |
Efficacy of antiviral therapies for COVID-19: a systematic review of randomized controlled trials. | 2022 | BMC Infectious Diseases |
Comparative efficacy and safety of pharmacological interventions for severe COVID-19 patients: an updated network meta-analysis of 48 randomized controlled trials. | 2022 | Medicine |
Efficacy of pharmacological interventions in COVID-19: a network meta-analysis. | 2022 | British Journal of Clinical Pharmacology |
The clinical efficacy and safety of anti-viral agents for non-hospitalized patients with COVID-19: a systematic review and network meta-analysis of randomized controlled trials. | 2022 | Viruses |
Remdesivir for the treatment of patients hospitalized with COVID‑19 receiving supplemental oxygen: a targeted literature review and meta‑analysis. | 2022 | Scientific Reports |
Adverse effects of remdesivir, hydroxychloroquine and lopinavir/ritonavir when used for COVID-19: systematic review and meta-analysis of randomised trials. | 2022 | BMJ Open |
Efficacy of COVID-19 treatments among geriatric patients: a systematic review. | 2022 | Therapeutic Advances in Infectious Disease |
Remdesivir administration in COVID-19 patients with renal impairment: a systematic review. | 2022 | American Journal of Therapeutics |
Use of remdesivir in patients with COVID-19: a systematic review and meta-analysis. | 2022 | Jornal Brasileiro de Pneumologia |
Major update 2: Remdesivir for adults with COVID-19: a living systematic review and meta-analysis for the American College of Physicians practice points. | 2022 | Annals of Internal Medicine |
Efficacy and safety of remdesivir in hospitalised COVID-19 patients: a systematic review and meta-analysis. | 2022 | Infection |
Remdesivir for the treatment of COVID-19: a systematic review and meta-analysis. | 2022 | Clinical Microbiology and Infection |
Remdesivir: a potential game-changer or just a myth? A systematic review and meta-analysis. | 2021 | Life Sciences |
Remdesivir for treatment of COVID-19; an updated systematic review and meta-analysis. | 2021 | European Journal of Pharmacology |
Efficacy and safety of remdesivir in COVID-19 caused by SARS-CoV-2: a systematic review and meta-analysis. | 2021 | BMJ Open |
Major update: remdesivir for adults with COVID-19: a living systematic review and meta-analysis for the American College of Physicians practice points. | 2021 | Annals of Internal Medicine |
Effectiveness of remdesivir, lopinavir/ritonavir, and favipiravir for COVID-19 treatment: a systematic review. | 2021 | International Journal of General Medicine |
Clinical efficacy and safety of remdesivir in patients with COVID-19: a systematic review and network meta-analysis of randomized controlled trials. | 2021 | Journal of Antimicrobial Chemotherapy |
Remdesivir for the treatment of coronavirus COVID-19: a meta-analysis of randomised controlled trials. | 2021 | Journal of Global Antimicrobial Resistance |
Remdesivir for coronavirus disease 2019 (COVID-19): a systematic review with meta-analysis and trial sequential analysis of randomized controlled trials. | 2021 | Infectious Diseases |
Efficacy of COVID-19 treatments: a Bayesian network meta-analysis of randomized controlled trials. | 2021 | Frontiers in Public Health |
Current evidence for COVID-19 therapies: a systematic literature review. | 2021 | European Respiratory Review |
Immunomodulatory therapies for SARS-CoV-2 infection: a systematic literature review to inform EULAR points to consider. | 2021 | Annals of the Rheumatic Diseases |
Interventions for treatment of COVID-19: second edition of a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project). | 2021 | PLoS One |
Comparative effectiveness of pharmacological interventions for Covid-19: a systematic review and network meta-analysis. | 2021 | Frontiers in Pharmacology |
Antiviral drugs for coronavirus disease 2019 (COVID-19): a systematic review with network meta-analysis. | 2021 | Expert Review of Anti-infective Therapy |
Remdesivir and its antiviral activity against COVID-19: a systematic review. | 2021 | Clinical Epidemiology and Global Health |
Remdesivir therapy in patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials. | 2021 | Annals of Medicine and Surgery |
Remdesivir for adults with COVID-19: a living systematic review for American College of Physicians practice points. | 2021 | Annals of Internal Medicine |
The safety, tolerability and mortality reduction efficacy of remdesivir; based on randomized clinical trials, observational and case studies reported safety outcomes: an updated systematic review and meta-analysis. | 2021 | Therapeutic Advances in Drug Safety |
Third force in the treatment of COVID-19: a systematic review and meta-analysis. | 2021 | Annals of Medicine and Surgery |
Protocol: Benefits and harms of remdesivir for COVID-19 in adults: a systematic review with meta-analysis. | 2021 | PloS One |
Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: a systematic review and network meta-analysis. | 2020 | PLoS Medicine |
Immune therapy, or antiviral therapy, or both for COVID-19: a systematic review. | 2020 | Drugs |
SARS-CoV-2 pharmacologic therapies and their safety/effectiveness according to level of evidence. | 2020 | American Journal of Emergency Medicine |
Evaluation of current medical approaches for COVID-19: a systematic review and meta-analysis. | 2020 | BMJ Supportive & Palliative Care |
Interventions for treatment of COVID-19: a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project). | 2020 | PLOS Medicine |
Drug treatments for covid-19: living systematic review and network meta-analysis. | 2020 | BMJ |
Efficacy of various treatment modalities for nCOV-2019: a systematic review and meta-analysis. | 2020 | European Society for Clinical Investigation |
Efficacy and harms of remdesivir for the treatment of COVID-19: a systematic review and meta-analysis. | 2020 | PLoS One |
Systematic review on the therapeutic options for COVID-19: Clinical evidence of drug efficacy and implications. | 2020 | Infection and Drug Resistance |